Silva, G., Sales-Dias, J., Casal, D., Alves, S., Domenici, G., Barreto, C., . . . Barbas, A. (2021). Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer.
Chicago Style (17th ed.) CitationSilva, G., et al. Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy Against Estrogen Receptor-Positive Breast Cancer. 2021.
MLA (8th ed.) CitationSilva, G., et al. Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy Against Estrogen Receptor-Positive Breast Cancer. 2021.
Warning: These citations may not always be 100% accurate.